BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 8026189)

  • 1. Biology of proinflammatory cytokines and their antagonists.
    Moldawer LL
    Crit Care Med; 1994 Jul; 22(7):S3-7. PubMed ID: 8026189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mediators of septic shock: new approaches for interrupting the endogenous inflammatory cascade.
    Giroir BP
    Crit Care Med; 1993 May; 21(5):780-9. PubMed ID: 8482101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sepsis and its complications: the clinical problem.
    Bone RC
    Crit Care Med; 1994 Jul; 22(7):S8-11. PubMed ID: 8026190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current prospects for the treatment of clinical sepsis.
    Suffredini AF
    Crit Care Med; 1994 Jul; 22(7):S12-8. PubMed ID: 8026188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor necrosis factor: an updated review of its biology.
    Tracey KJ; Cerami A
    Crit Care Med; 1993 Oct; 21(10 Suppl):S415-22. PubMed ID: 8403979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cytokines and antagonists in septic shock].
    Girardin E; Dayer JM
    Schweiz Med Wochenschr; 1993 Mar; 123(11):480-91. PubMed ID: 8386392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumour necrosis factor (cachectin) and other cytokines in septic shock: a review of the literature.
    Dofferhoff AS; Vellenga E; Limburg PC; van Zanten A; Mulder PO; Weits J
    Neth J Med; 1991 Aug; 39(1-2):45-62. PubMed ID: 1961351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine and anti-cytokine strategies in inflammatory reaction modulation.
    Delannoy I; Lekeux P; Miossec P
    Vet Res; 1993; 24(6):449-67. PubMed ID: 8111428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis factor in the pathogenesis of infectious diseases.
    Beutler B; Grau GE
    Crit Care Med; 1993 Oct; 21(10 Suppl):S423-35. PubMed ID: 8403980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of anti-tumor necrosis factor-alpha and interleukin-10 in protecting murine neonates from Escherichia coli sepsis.
    Lally KP; Cruz E; Xue H
    J Pediatr Surg; 2000 Jun; 35(6):852-4; discussion 855. PubMed ID: 10873025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-18 induces production of proinflammatory cytokines in mice: no intermediate role for the cytokines of the tumor necrosis factor family and interleukin-1beta.
    Netea MG; Kullberg BJ; Verschueren I; Van Der Meer JW
    Eur J Immunol; 2000 Oct; 30(10):3057-60. PubMed ID: 11069090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor-beta1 blocks in vitro cardiac myocyte depression induced by tumor necrosis factor-alpha, interleukin-1beta, and human septic shock serum.
    Kumar A; Kumar A; Paladugu B; Mensing J; Parrillo JE
    Crit Care Med; 2007 Feb; 35(2):358-64. PubMed ID: 17204997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Major role for interleukin 1 but not for tumor necrosis factor in early cartilage damage in immune complex arthritis in mice.
    Van Lent PL; Van De Loo FA; Holthuysen AE; Van Den Bersselaar LA; Vermeer H; Van Den Berg WB
    J Rheumatol; 1995 Dec; 22(12):2250-8. PubMed ID: 8835558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapeutic strategies against mediators of septic shock].
    Zabel P; Schade FU
    Immun Infekt; 1993 Apr; 21(2):45-50. PubMed ID: 8340137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of TNF-alpha and cytokines in the physiopathology of rheumatoid arthritis. Therapeutic perspectives].
    Meyer O
    Bull Acad Natl Med; 2003; 187(5):935-54; discussion 954-5. PubMed ID: 14979058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endotoxin, tumor necrosis factor, and related mediators: new approaches to shock.
    Beutler B
    New Horiz; 1993 Feb; 1(1):3-12. PubMed ID: 7922391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic inflammatory response to exhaustive exercise. Cytokine kinetics.
    Suzuki K; Nakaji S; Yamada M; Totsuka M; Sato K; Sugawara K
    Exerc Immunol Rev; 2002; 8():6-48. PubMed ID: 12690937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology, pathophysiology and clinical presentation of gram-negative sepsis.
    Hazinski MF; Iberti TJ; MacIntyre NR; Parker MM; Tribett D; Prion S; Chmel H
    Am J Crit Care; 1993 May; 2(3):224-35; quiz 236-7. PubMed ID: 8364674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The duration of hypotension before the initiation of antibiotic treatment is a critical determinant of survival in a murine model of Escherichia coli septic shock: association with serum lactate and inflammatory cytokine levels.
    Kumar A; Haery C; Paladugu B; Kumar A; Symeoneides S; Taiberg L; Osman J; Trenholme G; Opal SM; Goldfarb R; Parrillo JE
    J Infect Dis; 2006 Jan; 193(2):251-8. PubMed ID: 16362889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiopulmonary bypass-induced inflammation: is it important?
    Hill GE
    J Cardiothorac Vasc Anesth; 1998 Apr; 12(2 Suppl 1):21-5. PubMed ID: 9583572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.